Sonodynamic-Chemoradiotherapy Integration in Glioblastoma

PHASE2Enrolling by invitationINTERVENTIONAL
Enrollment

230

Participants

Timeline

Start Date

October 1, 2024

Primary Completion Date

August 1, 2028

Study Completion Date

October 1, 2028

Conditions
Glioblastoma (GBM)
Interventions
PROCEDURE

Sonodynamic Therapy (SDT)

SDT: Hematoporphyrin 5 mg/kg.Sonodynamic therapy is administered 40 hours later, twice a day with an interval of 10-12 hours, for 5 consecutive days. One cycle lasts 28 days, and a total of 4-6 cycles are conducted.

OTHER

Standard Treatment

Radiotherapy: The dose is 50-54 Gy, 1.8-2 Gy per day, 5 times a week, for a total of 25 sessions Chemotherapy: When temozolomide is administered concurrently with radiotherapy, the dose is 75 mg/m² per day, taken daily until the end of radiotherapy. For adjuvant chemotherapy with temozolomide, the dose is 150 mg/m² per day from day 1 to day 5, followed by a 23 - day rest period. Each cycle lasts 28 days. If well - tolerated, the dose should be adjusted to 200 mg/m² per day for the 2nd - 6th cycles Targeted Therapy: Bevacizumab 7.5-10 mg/kg, once every 3 weeks, for a total of 4-6 courses

Trial Locations (1)

450000

First H A Zhengzhou U, Zhengzhou

All Listed Sponsors
lead

Yingjuan Zheng

OTHER